J.R. Garabatos-Perera, H. Butenschön / Journal of Organometallic Chemistry 694 (2009) 2047–2052
2051
1
H, OH) ppm. 13C NMR (100 MHz, BB, HMQC, HMBC, CDCl
CCH ), 22.7 (CCH ), 49.5 (OCH ), 65.6 (CRCpR), 68.0 (CHCpR), 68.3
CH ), 70.4 (CHCpR), 70.6 (CHCpH), 75.0 (CHCpR), 75.4 (COCH ), 73.7
NCH), 77.3 (COH), 101 (CRCpR), 126.2 (Ph), 126.5 (Ph), 127.0 (Ph),
27.1 (Ph), 127.3 (Ph), 127.8 (Ph), 146.3 (Ph), 149.1 (Ph), 158.4
3
): d 20.5
pure 1,1-bisferrocenylpentan-1-ol [24] (0.154 g, 0.3 mmol, 24%,
characterized crystallographically [25]) as yellow crystals and
pure (S,pR)-12 (0.564 g, 0.8 mmol, 48%, >95% de) as a yellow
foam.
(
(
(
3
3
3
2
3
D
ꢀ1
1
(S,R
P
)-12: ½
a
ꢂ
¼ þ94 (c = 0.10, CHCl
3
). IR (ATR):
m
~ ¼ 3095cm
2
0
+
+
+
1
(
[
5
OCN) ppm. MS (ESI, ES ): m/z = 492 [M –OH], 510 [M+H ], 532
(w, OH), 2958 (w), 1650 (s, C@N), 814 (s). H NMR (400 MHz,
+
3
), 1.15 (d, 3J = 6.8 Hz, 3H,
M+Na ]. HRMS (ESI) (C30
10.1732 [M+H]. C30 31FeNO
Found: C, 70.64; H, 6.09; N, 2.69%.
3
H32FeNO ): Calc.: 510.1732; found:
CDCl
CH
3 3
): d 1.09 (d, J = 6.8 Hz, 3H, CH
H
3
: Calc.: C, 70.73; H, 6.13; N, 2.75.
3
), 2.12–1.98 [m, 1H, CH(CH ], 3.88 (s, 5H, CpH), 3.89 (m, 1H,
CpR ), 3.95 (m, 1H, CpR ), 4.04 (s, 5H, CpH), 4.05 (m, 1H, CpR ),
.07 (s, 5H, CpH), 4.09 (m, 2H, 2 ꢁ CpR), 4.16 (m, 2H, 2 ꢁ CpR),
4.16 (m, ABX line system, 2H, OCH ), 4.26 (m, 1H, CpR), 4.34 (m,
ABX line system, 1H, NCH), 4.63 (m, 1H, CpR), 4.72 (m, 1H, CpR),
3 2
)
2
2
2
4
4.6. (S,pR)-2-[(2-Diphenylhydroxymethyl)ferrocenyl]-4-
2
isopropyloxazoline [(S,pR)-10]
1
3
4
.75 (m, 1H, CpR), 8.95 (s, 1H, OH) ppm. - C NMR (100 MHz,
GP1; (S)-2-ferrocenyl-4-isopropyloxazoline [(S)-9, 0.504 g,
BB, HMQC, HMBC, CDCl ): d 18.0 (CH ), 19.2 (CH ), 32.0 [CH(CH ],
3
3
3
3 2
)
1
.7 mmol], TMEDA (0.33 mL, 2.2 mmol), Et
2
O
(6.3 mL), BuLi
64.8 (CR-CpR), 65.8 (CH-CpR), 65.9 (CR-CpR), 66.2 (CH-CpR), 66.5
(CH-CpR), 66.7 (CH-CpR), 67.6 (CH-CpR), 67.8 (CH-CpR), 68.1 (CH-
CpR), 68.4 (CH-CpR), 68.5 (CH-CpH), 69.0 (CH-CpH), 69.4 (NCH),
69.9 (CH-CpR), 70.8 (CH-CpH), 72.0 (C-12), 72.2 (CH-CpR), 73.5
(CH-CpR), 100.0 (CR-CpR), 100.3 (COH), 101.1 (CR-CpR), 168.5
(
1.4 mL, 1.6 M in hexane, 2.2 mmol), benzophenone (0.309 g,
1
.7 mmol), column chromatography (SiO
2
deactivated with a 5%
Et Cl
3
N solution in PE, 25 ꢁ 4 cm, PE/CH
2
2
10:1) gave pure (S,pR)-
1
0 (0.777 g, 1.6 mmol, 96%, >95% de) as a yellow-red solid. Recrys-
tallization from hexane gave crystals of (S,pR)-10 (0.511 g,
.1 mmol, 63%, >95% de, m.p. 135 °C).
+
+
+
(NCO) ppm. MS (ESI, ES ): m/z = 678 [M –OH], 695 [M ]. HRMS
+
1
(ESI) (C37 NO
H
37Fe
3
2
): Calc.: 695.0872; found: 695.0897 [M ].
D
ꢀ1
½
aꢂ
¼ ꢀ366 (c = 0.12, CHCl
3
). IR (ATR):
OH), 3056 (w, Cp-H), 2954 (w), 2873 (w), 1650 (s, C@N).
NMR (400 MHz, CDCl
): d 0.98 (d, 3J = 6.8 Hz, 3H, CH
), 1.83–1.75 [m, 1H, CH(CH
m
~ ¼ 3514 cm
(w,
H
C
37
H
37Fe NO : Calc.: C, 63.92; H, 5.36; N, 2.01. Found: C, 64.37;
3
2
2
0
1
H, 5.57; N, 1.92%.
3
3
), 1.05 (d,
], 3.67–3.61
Jcis = 9.8 Hz,
3
J = 6.7 Hz, 3H, CH
3
3
)
2
4.8. (S,pR,R)-2-(2-Ferrocenylphenylhydroxymethylferrocenyl)-4-
isopropyloxazoline (S,pR,R)-11 and (S,pR,S)-2-(2-ferrocenylphenyl-
hydroxymethylferrocenyl)-4-isopropyl-oxazoline (S,pR,S)-11
ddd, ABMX line system, J = 6.4 Hz, 3
3
J
trans = 8.4 Hz,
3
(
1
H, NCH), 3.72 (dd, J = 1.6 Hz, J = 2.5 Hz, 1H, CpR), 3.98 (dd, ABX
3
2
line system,
system,
J
trans = Jgem = 8.3 Hz, 1H, OCH
2
), 4.17 (dd, ABX line
), 4.27 (t, J = 2.5 Hz,
2
gem = 8.4 Hz, 3Jcis = 9.8 Hz, 1H, OCH
J
2
GP1; (S)-2-ferrocenyl-4-isopropyloxazoline [(S)-9, 0.507 g,
1
H, CpR), 4.28 (s, 5H, CpH), 4.76 (dd, J = 1.6 Hz, J = 2.5 Hz, 1H,
CpR), 7.14–7.18 (m, 5H, Ph), 7.24–7.36 (m, 3H, Ph), 7.53–7.55
m, 2H, Ph), 9.3 (s, 1H, OH) ppm. 13C NMR (100 MHz, BB, DEPT,
2
1.7 mmol], TMEDA (0.3 mL, 2.2 mmol), Et O (2.5 mL), BuLi
(1.4 mL, 1.6 M in hexane, 2.2 mmol), benzoylferrocene [26]
(0.493 g, 1.7 mmol) solution in anhydrous THF (20 mL), column
(
CDCl
3
): d 18.6 (CH
7.9 (NCH), 70.0 (CpR
4.9 (CpR ), 77.2 (CpR
27.0 (Ph), 127.1 (Ph), 127.4 (Ph), 127.8 (Ph), 146.4 (Ph), 149.2
3
), 18.8 (CH
), 70.4 (CH
), 100.5 (CPh
3
), 32.4 [CH(CH
3
)
2
], 66.0 (CpR
2
),
),
chromatography (SiO
25 ꢁ 4 cm, PE/EE 9:1) gave a 3:1 or 1:3 mixture of diastereoiso-
mers (S,R ,R)-11 and (S,R ,S)-11 (0.802 g, 1.4 mmol, 80%, >95% de
) as a red oil. Recrystallization from TBME gave a 2.5:1 mixture
of diastereoisomers (0.491 g, 0.8 mmol, 49%, >95% de R ) as yellow
2
,
deactivated with Et
3
N
5% in PE,
6
7
1
2
2
), 70.6 (CpH), 71.5 (CpR
2
2
2
2
) 126.2 (Ph), 126.5 (Ph),
P
P
R
P
+
+
(
[
4
Ph), 167.5 (OCN) ppm. MS (ESI, ES ): m/z = 462 [M –OH], 480
P
+
M+H ]. HRMS (ESI) (C29
80.1606 [M+H]. C29 29FeNO
Found: C, 72.33; H, 5.95; N, 2.80%.
Crystal Structure Analysis of (S,pR)-10 : C29
2
H30FeNO ): Calc.: 480.1626; found:
crystals. The analytical data did not allow a clear cut assignment of
H
2
: Calc.: C, 72.66; H, 6.10; N, 2.92.
the diastereomers.
D
(S,pR,R)-11 and (S,R
P
,S)-11: ½
aꢂ
¼ ꢀ24 (c = 0.20, CHCl
3
). IR
2
0
ꢀ1
H
29FeNO
weight, 479.38 g mol , temperature 297 K, crystal system tetrag-
onal, space group P4 2 (No. 92), a = 11.851(3), b = 11.851(3),
c = 35.173(15) Å, = 90°, b = 90°,
2
, molecular
(ATR):
1648 (s, C@N). MS (ESI, ES ): m/z: 570 [M –OH], 588 [M+H ]. HRMS
(ESI) (C33 NO): Calc.: 570.1183; found: 570.1171 [M–OH].
33Fe : Calc.: C, 67.49; H, 5.66; N, 2.38. Found: C, 67.48;
m
~ ¼ 3095 cm (w, OH), 2961 (w), 2928 (w), 2871 (w),
ꢀ1
+ + +
1
2
1
H32Fe
2
3
a
c
= 90°, V = 4940(3) Å , Z = 8,
F(000) = 2016, Absorption coefficient =
.636 mm , crystal size 0.21 ꢁ 0.14 ꢁ 0.14 mm, Stoe IPDS area
detector diffractometer, h range = 1.81–24.24°, limiting indices
13 6 h 6 13, –13 6 k 6 13, –40 6 l 6 40, reflections collected/
unique 53815/3979 [Rint = 0.1239], completeness of data
h = 24.24): 99.5%, empirical absorption correction (multi-scan),
no extinction correction, refinement method full-matrix least-
C
33
H
2 2
NO
ꢀ3
q
0
calc = 1.289 g cm
,
H, 5.47; N, 2.13%.
ꢀ
1
1
(S,pR,R)-11 or (S,R
P
,S)-11: H NMR (400 MHz, CDCl
3
): d 0.99 (d,
3
3
J = 6.8 Hz, 3H, CH
3
), 1.10 (d, J = 6.6 Hz, 3H, CH
3
), 1.8–1.9 [m, 1H,
–
CH(CH
J = 15.9 Hz, 1H, NCH), 3.66 (s, 1H, CpR), 3.88 (m, ABX line system,
1H, OCH ), 3.90 (m, 1H, CpR), 4.04 (s, 5H, CpH), 4.06 (d, 1H,
J = 1.4 Hz, CpR), 4.10 (m, 1H, OCH ), 4.16 (dd, J = J = 2.6 Hz, 1H,
3 2
) ], 3.62 (ddd, ABMX line system, J = 6.5 Hz, J = 9.4 Hz,
(
2
2
2
2
squares on F , goodness-of-fit on F = 0.708, R
.0338 (I > 2 (I)), R-indices [all data]: R = 0.0808, wR
minimal and maximal residual electron density –0.267/0.162
1
= 0.0302, wR
2
=
CpR), 4.25 (s, 5H, CpH), 4.27 (m, 1H, CpR), 4.54 (dd, 1H,
J = 1.6 Hz, J = 2.4 Hz, CpR), 4.71 (dd, J = J = 1.1 Hz, 1H, CpR), 7.10–
0
r
1
2
= 0.0391,
7.50 (m, 4H, Ph), 7.78 (d, J = 7.2 Hz, 1H, Ph), 8.71 (s, 1H, OH)
ꢀ
3
13
eÅ
.
ppm. - C NMR (100 MHz, BB, CDCl
3
3
): d 18.6 (CH
], 65.1 [CR-CpR (CFcCOH)], 66.9 (CH-CpR), 67.0
(CH-CpR), 67.1 (CH-CpR), 67.3 (CH-CpR), 68.4 (CH-CpR), 68.8 (CH-
CpH), 69.77 (CH-CpR), 69.84 (OCH ), 70.6(CH-CpH), 71.7 (NCH),
4.12 (CH-CpR), 74.3 [CR-CpR(CFcCOH)], 96.63 (COH), 102.8 [CR-
3 3
), 19.3 (CH ),
3 2
2.4 [CH(CH )
4.7. (S,pR)-2-[2-(Diferrocenylhydroxymethyl)ferrocenyl]-4-
isopropyloxazoline (S,pR)-12
2
7
GP1; (S)-2-ferrocenyl-4-isopropyloxazoline [(S)-9] 0.503 g,
CpR(CFcCN)], 126.4 (Ph), 126.8 (Ph), 127.7 (Ph), 147.6 (Ph), 170.4
1
.7 mmol], TMEDA (0.33 mL, 2.2 mmol), Et
2
O
(6.3 mL), BuLi
(NCO) ppm.
(
(
1.4 mL, 1.6 M in hexane, 2.2 mmol), diferrocenylketone [14,15]
0.678 g, 1.7 mmol) solution in anhydrous THF (20 mL); column
(S,pR,R)-11 or (S,R
J = 6.6 Hz, 3H, CH
CH(CH
3 ꢁ 1H, CpR), 4.02 (s, 5H, CpH), 4.03 (s, 5H, CpH), 4.1–4.2 (m,
ABX line system, 2H, OCH or NCH), 4.24 (m, 1H, CpR), 4.39 (m,
P
,S)-11: 1H NMR (400 MHz, CDCl
3
): d 1.1 (d,
3
3
3
3
), 1.2 (d, J = 6.8 Hz, 3H, CH ), 1.95 [m, 1H,
chromatography (SiO
2
6
2
deactivated with Et
10:1) gave (S,R )-12 (0.718 g, 1.0 mmol,
1%, >95% de) as a red liquid. Crystallization from TBME gave
3
N
5% in PE,
3 2
) ], 3.76 (m, 1H, CpR), 3.86–3.90 (m, 1H, CpR), 4.0–4.2 (m,
5 ꢁ 4 cm, PE/CH
2
Cl
2
P
2